Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 54.13%384.88M | 475.83%1.75B | 285.21%822.75M | -20.19%1.02B | -35.53%251.51M | -5.16%249.71M | -8.76%303.71M | -26.31%213.59M | -9.09%1.28B | -23.49%390.11M |
| Cost of revenue | 60.22%354.81M | 496.06%1.68B | 306.62%787.67M | -22.55%913.67M | -39.59%216.6M | -9.19%221.45M | -8.91%281.91M | -27.85%193.71M | -8.84%1.18B | -24.09%358.57M |
| Gross profit | 6.43%30.08M | 214.18%68.48M | 76.52%35.08M | 8.78%104.84M | 10.66%34.91M | 45.34%28.26M | -6.79%21.8M | -6.90%19.88M | -12.04%96.38M | -15.81%31.55M |
| Operating expense | 41.93%24.61M | 55.93%19.5M | 27.82%18.49M | 24.58%71.92M | 33.05%17.16M | 27.05%17.34M | 18.68%12.51M | 44.62%14.47M | 19.64%57.73M | -9.73%12.89M |
| Selling and administrative expenses | 39.33%27.43M | 49.36%22.35M | 26.61%21.54M | 23.90%72.01M | 22.21%20.35M | 16.98%19.69M | 19.27%14.96M | 40.68%17.01M | 3.08%58.12M | 3.23%16.65M |
| -Selling and marketing expense | 55.47%15.95M | 58.14%14.88M | 37.33%15.46M | 33.27%45.06M | 28.26%14.14M | 30.00%10.26M | 26.51%9.41M | 50.84%11.26M | -4.45%33.81M | 4.96%11.02M |
| -General and administrative expense | 21.76%11.48M | 34.49%7.47M | 5.65%6.08M | 10.87%26.95M | 10.37%6.21M | 5.48%9.43M | 8.71%5.55M | 24.30%5.76M | 15.78%24.31M | 0.01%5.63M |
| Total other operating income | 20.17%2.82M | 15.89%2.85M | 19.75%3.04M | -77.06%89.59K | -15.02%3.19M | -26.17%2.35M | 22.32%2.46M | 21.80%2.54M | -95.20%390.55K | 103.62%3.76M |
| Operating profit | -49.91%5.47M | 427.26%48.98M | 206.88%16.59M | -14.82%32.92M | -4.81%17.75M | 88.42%10.92M | -27.70%9.29M | -52.34%5.41M | -36.97%38.65M | -19.56%18.65M |
| Net non-operating interest income (expenses) | -62.61%-2.27M | -65.74%-1.74M | -67.73%-1.89M | 117.78%260.12K | -13.40%-1.08M | -15.09%-1.4M | 14.31%-1.05M | 20.40%-1.13M | 69.46%-1.46M | 31.46%-955K |
| Non-operating interest income | ---- | ---- | ---- | 46.96%4.92M | ---- | ---- | ---- | ---- | --3.34M | ---- |
| Non-operating interest expense | 62.61%2.27M | 65.74%1.74M | 67.73%1.89M | -1.02%3.71M | 13.40%1.08M | 15.09%1.4M | -14.31%1.05M | -20.40%1.13M | 44.77%3.75M | 218.63%955K |
| Total other finance cost | ---- | ---- | ---- | -10.78%942.59K | ---- | ---- | ---- | ---- | -51.94%1.06M | ---- |
| Net investment income | 18.18%130K | 12.05%93K | -73.26%46K | -41.50%82.54K | -75.67%64K | 254.84%110K | 260.87%83K | 681.82%172K | -34.65%141.09K | 195.82%263K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -9.09%1.11M | 95.42%1.22M | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 938.35%6.69M | -20,236.61%-22.78M | -85.11%39K | 149.40%1.09M | 367.74%290K | 130.32%644K | -96.49%-112K | 354.37%262K | -28,206.72%-2.21M | 894.57%62K |
| Less:Other special charges | ---- | ---- | ---- | 33.16%-6.99K | ---- | ---- | ---- | ---- | 97.02%-10.46K | ---- |
| Less:Write off | -938.35%-6.69M | 20,236.61%22.78M | 85.11%-39K | -148.85%-1.08M | -367.74%-290K | -130.32%-644K | 96.49%112K | -354.37%-262K | 517.46%2.22M | -117.25%-62K |
| Other non-operating income (expenses) | -4,356.41%-1.66M | 1,269.06%2.48M | -440.25%-1.34M | -16.44%5.96M | 75.76%580K | -90.44%39K | -41.23%181K | -16.84%395K | 7.14M | 330K |
| Income before tax | -19.01%8.36M | 222.10%27.03M | 163.15%13.44M | -4.71%41.42M | -4.07%17.61M | 256.04%10.32M | -29.46%8.39M | -50.51%5.11M | -24.22%43.47M | -16.94%18.35M |
| Income tax | -1,523.77%-1.74M | 216.11%6.47M | 134.14%3.2M | -3.35%11.12M | 42.66%7.59M | -86.14%122K | -28.74%2.05M | -43.92%1.37M | -15.68%11.51M | -0.10%5.32M |
| Net income | -1.00%10.09M | 224.03%20.56M | 173.73%10.24M | -5.19%30.3M | -23.13%10.02M | 405.25%10.2M | -29.69%6.35M | -52.55%3.74M | -26.89%31.96M | -22.28%13.04M |
| Net income continuous operations | -1.00%10.09M | 224.03%20.56M | 173.73%10.24M | -5.19%30.3M | -23.13%10.02M | 405.25%10.2M | -29.69%6.35M | -52.55%3.74M | -26.89%31.96M | -22.28%13.04M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -1.00%10.09M | 224.03%20.56M | 173.73%10.24M | -5.19%30.3M | -23.13%10.02M | 405.25%10.2M | -29.69%6.35M | -52.55%3.74M | -26.89%31.96M | -22.28%13.04M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -1.00%10.09M | 224.03%20.56M | 173.73%10.24M | -5.19%30.3M | -23.13%10.02M | 405.25%10.2M | -29.69%6.35M | -52.55%3.74M | -26.89%31.96M | -22.28%13.04M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -4.76%0.006 | 215.38%0.0123 | 165.22%0.0061 | -5.56%0.0187 | -24.69%0.0061 | 384.62%0.0063 | -30.36%0.0039 | -53.06%0.0023 | -60.24%0.0198 | -22.11%0.0081 |
| Diluted earnings per share | -3.33%0.0058 | 221.62%0.0119 | 160.87%0.006 | -8.59%0.0181 | -27.16%0.0059 | 361.54%0.006 | -33.93%0.0037 | -53.06%0.0023 | -60.24%0.0198 | -22.11%0.0081 |
| Dividend per share | 0.00%0.0025 | 0.00%0.0025 | -50.00%0.0013 | 33.33%0.01 | 0.00%0.0025 | 0.00%0.0025 | 0.00%0.0025 | 0.0025 | 200.00%0.0075 | 0.00%0.0025 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.